These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1297 related articles for article (PubMed ID: 29522745)

  • 21. How bacteria control the CRISPR-Cas arsenal.
    Leon LM; Mendoza SD; Bondy-Denomy J
    Curr Opin Microbiol; 2018 Apr; 42():87-95. PubMed ID: 29169146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical modelling of CRISPR-Cas system effects on biofilm formation.
    Ali Q; Wahl LM
    J Biol Dyn; 2017 Aug; 11(sup2):264-284. PubMed ID: 28426329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.
    Heussler GE; Cady KC; Koeppen K; Bhuju S; Stanton BA; O'Toole GA
    mBio; 2015 May; 6(3):e00129-15. PubMed ID: 25968642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas Technologies and Applications in Food Bacteria.
    Stout E; Klaenhammer T; Barrangou R
    Annu Rev Food Sci Technol; 2017 Feb; 8():413-437. PubMed ID: 28245154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The roles of CRISPR-Cas systems in adaptive immunity and beyond.
    Barrangou R
    Curr Opin Immunol; 2015 Feb; 32():36-41. PubMed ID: 25574773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditions for the spread of CRISPR-Cas immune systems into bacterial populations.
    Elliott JFK; McLeod DV; Taylor TB; Westra ER; Gandon S; Watson BNJ
    ISME J; 2024 Jan; 18(1):. PubMed ID: 38896653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-Cas systems: beyond adaptive immunity.
    Westra ER; Buckling A; Fineran PC
    Nat Rev Microbiol; 2014 May; 12(5):317-26. PubMed ID: 24704746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.
    Wright AV; Nuñez JK; Doudna JA
    Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.
    Richter C; Chang JT; Fineran PC
    Viruses; 2012 Oct; 4(10):2291-311. PubMed ID: 23202464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Host diversity limits the evolution of parasite local adaptation.
    Morley D; Broniewski JM; Westra ER; Buckling A; van Houte S
    Mol Ecol; 2017 Apr; 26(7):1756-1763. PubMed ID: 27862566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering.
    Liu Q; Zhang H; Huang X
    FEBS J; 2020 Feb; 287(4):626-644. PubMed ID: 31730297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.
    Fineran PC
    Microbiology (Reading); 2019 Aug; 165(8):834-841. PubMed ID: 30958259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Why so rare if so essentiel: the determinants of the sparse distribution of CRISPR-Cas systems in bacterial genomes].
    Bernheim A
    Biol Aujourdhui; 2017; 211(4):255-264. PubMed ID: 29956652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type II Anti-CRISPR Proteins.
    Hwang S; Maxwell KL
    J Mol Biol; 2023 Apr; 435(7):168041. PubMed ID: 36893938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation.
    Bhaya D; Davison M; Barrangou R
    Annu Rev Genet; 2011; 45():273-97. PubMed ID: 22060043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.